EMA Application withdrawn: Pelgraz Paediatric (pegfilgrastim) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA has withdrawn the application for Pelgraz Paediatric (pegfilgrastim) submitted by Accord Healthcare S.L.U., in the therapeutic areas of neutropenia, feb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Febrile Neutropenia
• Neutropenia

Drugs mentioned

• Pelgraz Paediatric (pegfilgrastim)

Snippet

Status: Application withdrawn. Therapeutic area: Neutropenia;Febrile Neutropenia;Cancer. MAH: Accord Healthcare S.L.U.